The institute operates multiple locations, including its flagship campus at Harper University Hospital and additional sites at Karmanos Cancer Institute at Wayne State University, Karmanos Cancer Institute at Detroit Medical Center, and Karmanos Cancer Institute at St. John Hospital and Medical Center. It serves a diverse patient population, with a strong focus on urban and underserved communities in the Detroit metropolitan area.
Karmanos Cancer Institute is organized into several research programs, including cancer biology, cancer control, cancer prevention, cancer therapy, and cancer survivorship. Its research spans basic science, translational research, and clinical trials, aiming to improve cancer detection, treatment, and survival rates. The institute also emphasizes community outreach, education, and training for healthcare professionals and the public.
Notable achievements include advancements in cancer genomics, immunotherapy, and personalized medicine. Karmanos has been involved in groundbreaking clinical trials, such as those exploring novel immunotherapies and targeted therapies for various cancers, including breast, lung, prostate, and blood cancers. The institute collaborates with national and international research networks to accelerate discoveries and improve patient outcomes.
In addition to its clinical and research efforts, Karmanos Cancer Institute is a major educational hub, offering residency and fellowship programs in oncology, as well as continuing education for healthcare providers. It also provides support services, including counseling, nutrition, and palliative care, to enhance the quality of life for patients and their families.
Funding for Karmanos Cancer Institute comes from a combination of federal grants, private donations, and institutional support. The institute relies heavily on philanthropy to sustain its mission, with ongoing campaigns and initiatives aimed at raising awareness and funds for cancer research and patient care.